Vriens D - Search Results

1

¹⁸F-FDG PET-CT versus MRI for detection of skeletal metastasis in Ewing sarcoma.

Bosma SE, Vriens D, Gelderblom H, van de Sande MAJ, Dijkstra PDS, Bloem JL. Bosma SE, et al. Among authors: vriens d. Skeletal Radiol. 2019 Nov;48(11):1735-1746. doi: 10.1007/s00256-019-03192-2. Epub 2019 Apr 23. Skeletal Radiol. 2019. PMID: 31016339 Free PMC article.

2

A clinically applicable molecular classification of oncocytic cell thyroid nodules.

de Koster EJ, Corver WE, de Geus-Oei LF, Oyen WJG, Ruano D, Schepers A, Snel M, van Wezel T, Vriens D, Morreau H. de Koster EJ, et al. Among authors: vriens d. Endocr Relat Cancer. 2023 Aug 3;30(9):e230047. doi: 10.1530/ERC-23-0047. Print 2023 Sep 1. Endocr Relat Cancer. 2023. PMID: 37399519 Free PMC article.

3

Monitoring and predicting response to therapy with 18F-FDG PET in colorectal cancer: a systematic review.

de Geus-Oei LF, Vriens D, van Laarhoven HW, van der Graaf WT, Oyen WJ. de Geus-Oei LF, et al. Among authors: vriens d. J Nucl Med. 2009 May;50 Suppl 1:43S-54S. doi: 10.2967/jnumed.108.057224. J Nucl Med. 2009. PMID: 19403879 Free article. Review.

4

Comparison of two region of interest definition methods for metabolic response evaluation with [¹⁸F]FDG-PET.

Vriens D, De Geus-Oei LF, Van Laarhoven HW, Van Der Heijden HF, Krabbe PF, Visser EP, Oyen WJ. Vriens D, et al. Q J Nucl Med Mol Imaging. 2010 Dec;54(6):677-88. Q J Nucl Med Mol Imaging. 2010. PMID: 21221073

5

Vascular and metabolic response to bevacizumab-containing regimens in two patients with colorectal liver metastases measured by dynamic contrast-enhanced MRI and dynamic 18F-FDG-PET.

Vriens D, de Geus-Oei LF, Heerschap A, van Laarhoven HW, Oyen WJ. Vriens D, et al. Clin Colorectal Cancer. 2011 Mar 1;10(1):E1-5. doi: 10.3816/CCC.2011.n.010. Clin Colorectal Cancer. 2011. PMID: 21609927 Free article.

6

F-18 FDG PET/CT as a crucial guide toward optimal treatment planning in a case of postirradiation sarcoma 10 years after primary bone lymphoma of the pelvis.

de Rooy JW, Hambrock T, Vriens D, Flucke UE, van der Geest IC, van de Luijtgaarden AC, Schreuder BW, de Geus-Oei LF. de Rooy JW, et al. Among authors: vriens d. Clin Nucl Med. 2011 Jul;36(7):565-7. doi: 10.1097/RLU.0b013e318217561c. Clin Nucl Med. 2011. PMID: 21637060

7

FDG-PET/CT based response-adapted treatment.

de Geus-Oei LF, Vriens D, Arens AI, Hutchings M, Oyen WJ. de Geus-Oei LF, et al. Among authors: vriens d. Cancer Imaging. 2012 Sep 28;12(2):324-35. doi: 10.1102/1470-7330.2012.9006. Cancer Imaging. 2012. PMID: 23023063 Free PMC article. Review.

8

Cost-effectiveness of FDG-PET/CT for cytologically indeterminate thyroid nodules: a decision analytic approach.

Vriens D, Adang EM, Netea-Maier RT, Smit JW, de Wilt JH, Oyen WJ, de Geus-Oei LF. Vriens D, et al. J Clin Endocrinol Metab. 2014 Sep;99(9):3263-74. doi: 10.1210/jc.2013-3483. Epub 2014 May 29. J Clin Endocrinol Metab. 2014. PMID: 24873995

9

Anakinra injection site reaction on FDG PET/CT.

Arens AI, Vriens D, Janssen M, Simon A, Oyen WJ. Arens AI, et al. Among authors: vriens d. Clin Nucl Med. 2015 Jun;40(6):492-3. doi: 10.1097/RLU.0000000000000747. Clin Nucl Med. 2015. PMID: 25742228

10

Comparison of Tumor Uptake Heterogeneity Characterization Between Static and Parametric 18F-FDG PET Images in Non-Small Cell Lung Cancer.

Tixier F, Vriens D, Cheze-Le Rest C, Hatt M, Disselhorst JA, Oyen WJ, de Geus-Oei LF, Visser EP, Visvikis D. Tixier F, et al. Among authors: vriens d. J Nucl Med. 2016 Jul;57(7):1033-9. doi: 10.2967/jnumed.115.166918. Epub 2016 Mar 10. J Nucl Med. 2016. PMID: 26966161 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

59 results

Search Page

Filters